Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

David P Meeker

CEO, President at Rhythm Pharmaceuticals, Inc. (RYTM)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.1M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 14SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 6,439282,819 held (−2%) $101.75 $655K -10.8%
Sep 14SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 30,746252,073 held (−11%) $102.35 $3.1M -11.3%
Sep 14SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 8,698243,375 held (−3%) $103.43 $900K -12.2%
Sep 14SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 1,817241,558 held (−1%) $104.55 $190K -13.2%
Sep 14SEC RYTMRhythm Pharmaceuticals, Inc. Sell Plan 2,300239,258 held (−1%) $105.19 $242K -13.7%
  • Sell

    CEO, President David P Meeker sold $655K of RYTM at $101.75 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, President David P Meeker sold $3.1M of RYTM at $102.35 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, President David P Meeker sold $900K of RYTM at $103.43 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, President David P Meeker sold $190K of RYTM at $104.55 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, President David P Meeker sold $242K of RYTM at $105.19 — pre-scheduled 10b5-1 plan sale.